Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer
Kirsty J. Boyd
*
, Moira Kelly
*
Corresponding author for this work
Deanery of Molecular, Genetic and Population Health Sciences
Usher Institute
Centre for Population Health Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Palliative Therapy
100%
Dyspnea
100%
Advanced Cancer
100%
Morphine
100%
Sedation
40%
Confidence Interval
40%
Combination Therapy
20%
Side Effect
20%
Visual Analog Scale
20%
Dizziness
20%
Optimal Drug Dose
20%
Peak Expiratory Flow
20%
Drug Dose Regimen
20%
Medicine and Dentistry
Symptomatic Treatment
100%
Dyspnea
100%
Advanced Cancer
100%
Morphine
100%
Combination Therapy
20%
Side Effect
20%
Visual Analog Scale
20%
Dizziness
20%
Respiratory Physiology
20%
Drug Dose Regimen
20%
Optimal Drug Dose
20%
Adverse Effect
20%
Peak Expiratory Flow
20%
Pharmacology, Toxicology and Pharmaceutical Science
Dyspnea
100%
Morphine
100%
Advanced Cancer
100%
Side Effect
20%
Combination Therapy
20%
Dizziness
20%